Understand Your Health with the Preeclampsia Panel

Preeclampsia Panel
  • Shield IconSafe for both mother and baby
  • Shield IconAssess the preeclampsia risk throughout pregnancy
  • Shield IconSupport risk stratification for complications to guide appropriate delivery planning
  • Shield IconFree home sample collection
Preeclampsia Panel

  • Women who are pregnant for the first time

  • Pregnant women aged 35 and older

  • Pregnant women with a history of preeclampsia

  • Pregnant women with diabetes, autoimmune disease, chronic kidney disease, chronic hypertension, etc.

  • Pregnant women who are overweight or obese, with a BMI of 30 or higher

  • Pregnant women with multiple pregnancies

  • Pregnant women with a history of fetal growth restriction, stillbirth, preterm birth related to placental disorders

  • Pregnant women with a family history of preeclampsia

  • Pregnant women who conceived through assisted reproductive technologies

  • Pregnant women with an interval of more than 10 years between pregnancies

The Preeclampsia Panel includes a group of tests performed during pregnancy to help screen for the risk of preeclampsia and support appropriate clinical management.

Preeclampsia is a serious pregnancy complication characterized by high blood pressure and may also involve damage to multiple maternal organ systems. If not detected and managed promptly, it can pose significant risks to both the mother and baby.

Because of the potential severity of preeclampsia, healthcare professionals recommend that pregnant women who are at increased risk undergo appropriate preeclampsia testing as advised by their physician throughout pregnancy.


   1st Trimester Panel: Screens for the risk of preeclampsia during the first trimester and helps predict the likelihood of developing the condition later in pregnancy.

   2nd & 3rd Trimester Panel: Focuses on monitoring and assessing the risk of preeclampsia during the second and third trimesters.

*The test is performed using the technique approved by the Ministry of Health: “Quantitative measurement of Placental Growth Factor (PlGF).”

Đăng ký tư vấn nhanh!

Preeclampsia Panels

Turnaround Time

By 3:20 PM on the same day (1st Trimester)
If the Lab receives the sample before 9:00 AM, Monday to Saturday
By the following day (1st Trimester)
If the Lab receives the sample before 9:00 AM, Monday to Saturday
After 5 hours and 50 minutes on the same day
If the Lab receives the sample before 9:00 AM, Monday to Saturday
By 10:50 AM the following day
If the Lab receives the sample before 9:00 AM, Monday to Saturday

Pre-Test Instructions

  • Please provide the information from your ultrasound report and follow the Test Order Form (TOF) provided by your doctor
  • Stop taking supplements containing vitamin B7 (biotin) for at least 8 hours before testing, or for at least 72 hours if taking high-dose biotin supplements
  • Consult your doctor before stopping any medications or dietary supplements

Seasonal promotions

15%

15% OFF - National Health Screening Program

HOT SALE See promo
4,349,000 VND

Only 4,349,000 VND - Early Cancer & Chronic Disease Screening Panel

HOT SALE See promo
100% Sure Win

Lucky Wheel - 100% Guaranteed Gifts for the Soft Opening of New PSC

HOT SALE See promo
150,000 VND

Receive Vouchers of Up to 150,000 VND when referring friends via DIAG App

HOT SALE See promo
Home Sample Collection
FREE

Any time, any test

Book Now Home sample collection
Extensive Network Across Southern Vietnam
40+ PSCs

Ho Chi Minh City, Binh Duong, Vung Tau, Long An, Tien Giang, and more

View Locations locations

Why Choose DIAG?

Reliable Test Results at DIAG for Accurate Medical Diagnosis and Treatment

3,500,000+

Annual Test Volume

2,400+

Trusted Doctor Partners

350+

Affiliated Hospitals & Clinics

450+

Diverse Tests

Trusted by Leading Healthcare Partners

DIAG Committed to Operating in Accordance with International Standards and Regulations of the Ministry of Health

DIAG Utilizes Advanced Automated Technologies from Europe and the United States to Deliver Accurate and Reliable Test Results

img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery

Highly Qualified Laboratory Professionals

GS. BS. Ahmed Elsaifi
Prof. Dr. Ahmed Elsaifi

Chairman of the Board, DIAG Medical Center System

Leading authority in Laboratory Medicine across the Middle East

Over 50 years of experience

BS. Nguyễn Thị Hiếu Hòa
Dr. Nguyen Thi Hieu Hoa

Head of Laboratory

Over 35 years of experience

ThS. BS. Lê Thị Khánh Linh
Dr. Le Thi Khanh Linh

Genetic Counseling Physician

Over 25 years of clinical experience

 

Physicians Providing Test Result Consultation, Medical Examination, and Treatment

BS. CKII. Nguyễn Thị Ngọc Loan
Dr. Nguyen Thi Ngoc Loan

General Internal Medicine

Over 30 years of clinical experience

BS. CKI. Phạm Thị Bạch Thu
Dr. Pham Thi Bach Thu

Diagnostic Imaging

Over 25 years of clinical experience

BS. CKI. Lê Thị Hồng Vui
Dr. Le Thi Hong Vui

Obstetrics and Gynecology

Over 15 years of clinical experience

ThS. BS. Trần Ngọc Bảo Trâm
Dr. Tran Ngoc Bao Tram

Internal Medicine – General Internal Medicine

Over 10 years of clinical experience

BS. CKI. Trần Thanh An
Dr. Tran Thanh An

Infectious Diseases – General Pediatrics

Over 14 years of clinical experience

BS. Đinh Ngọc Hiểu
Dr. Dinh Ngoc Hieu

Internal Medicine

Over 8 years of clinical experience

BS. Nguyễn Ý Ngọc
Dr. Nguyen Y Ngoc

Internal Medicine – General Internal Medicine

Over 8 years of clinical experience

Frequently Asked Questions

A suitable time for early preeclampsia risk screening during the first trimester is approximately between 11 and 14 weeks of pregnancy.

Missing first-trimester screening does not mean that you will develop preeclampsia, or that the condition can no longer be detected. However, it does mean that an important opportunity for early risk stratification has been missed.

From the second trimester onward, doctors can continue monitoring blood pressure, urine protein levels, and fetal growth. When clinically indicated, blood tests or biomarkers such as PlGF or the sFlt-1/PlGF ratio may also be used to support further assessment.

The most important step is to continue attending prenatal checkups as scheduled and inform your doctor about any personal risk factors you may have.

Not necessarily. Preeclampsia risk can be screened early during the first trimester, typically between 11 and 14 weeks. After that, blood pressure and overall maternal health should continue to be assessed during routine prenatal visits.

The risk of preeclampsia should be monitored throughout pregnancy, while specific preeclampsia tests should be performed when appropriate and as recommended by your doctor.

The risk of preeclampsia may be higher in pregnant women with one or more of the following factors:

  • First pregnancy
  • Obesity
  • Advanced maternal age
  • Previous history of preeclampsia
  • Multiple pregnancy
  • Family history of preeclampsia
  • Chronic hypertension
  • Chronic kidney disease
  • Diabetes
  • Systemic lupus erythematosus
  • Antiphospholipid syndrome.

Having one or more risk factors does not mean that preeclampsia will definitely occur. These factors help doctors determine the appropriate level of monitoring and preventive care.

During pregnancy ultrasound, findings that suggest impaired placental function may be associated with an increased risk of preeclampsia. These may include an elevated uterine artery pulsatility index (PI) or the presence of early diastolic notching on Doppler ultrasound.

Later in pregnancy, fetal growth restriction or Doppler findings suggestive of impaired placental and fetal circulation may also suggest the preeclampsia testing.

However, doctors will interpret ultrasound findings together with maternal blood pressure, symptoms, and laboratory test results before deciding whether additional preeclampsia testing is necessary.

Book Test Zalo Button Messenger Button promotion